Aranesp is among the drugs listed on HRSA's latest manufacturer's notice posted on behalf of Amgen.

Amgen, Vertex, and AstraZeneca Post 340B Refund and Replenishment Public Notices

The U.S. Health Resources and Services Administration (HRSA) this week published notices from drug makers Amgen and Vertex about refunds [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at